<?xml version="1.0" ?>
<document id="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7">
  <chunk id="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7.c0" text="Hypothalamus-pituitary-adrenal axis involves in anti-viral ability through regulation of immune response in piglets infected by highly pathogenic porcine reproductive and respiratory syndrome virus">
    <entity charOffset="89-104" id="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7.c0.e0" ontology_id="GO_0006955" text="immune response" type="gene_function"/>
  </chunk>
  <chunk id="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7.c1" text="Background: The highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) has been responsible for several viral attacks in the Asian porcine industry, since the first outbreak in China in 2006. During the early stages of the HP-PRRSV infection, high levels of proinflammatory cytokines are noted in the host peripheral blood, which are accompanied by severe lesions in the lungs and immune system organs; these are considered as the greatest contributors to the overall disease burden. We hypothesized that the anti-PRRSV response in piglets might be mediated by the hypothalamus-pituitary-adrenal (HPA) axis, which led to a decrease in the psycho-neuroendocrinological manifestation of HP-PRRSV etiology via immune response regulation. Results: We investigated the regulation of the HPA axis in HP-PRRSV-infected piglets that were treated with 1 mg/ kg body weight (b. w.)/day mifepristone (RU486) or 2 mg/kg b.w./day dexamethasone (DEX). Both RU486 and DEX enhanced the disease status of the piglets infected by the HP-PRRSV HuN4 strain, resulting in high mortality and more severe pathological changes in the lungs. Conclusions: HP-PRRSV infection activates the HPA axis, and artificial regulation of the immune-endocrine system enhances disease severity in HP-PRRSV-infected piglets. Thus, DEX and RU486 should be avoided in the clinical treatment of HP-PRRS.">
    <entity charOffset="332-342" id="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7.c1.e0" ontology_id="HP_0030646" text="peripheral" type="phenotype"/>
    <entity charOffset="375-381" id="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7.c1.e1" ontology_id="HP_0012828" text="severe" type="phenotype"/>
    <entity charOffset="733-748" id="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7.c1.e2" ontology_id="GO_0006955" text="immune response" type="gene_function"/>
    <entity charOffset="1101-1107" id="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7.c1.e3" ontology_id="HP_0012828" text="severe" type="phenotype"/>
    <entity charOffset="1273-1281" id="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7.c1.e4" ontology_id="HP_0012824" text="severity" type="phenotype"/>
    <pair e1="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7.c1.e0" e2="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7.c1.e2" id="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7.c1.p0" relation="true"/>
    <pair e1="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7.c1.e1" e2="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7.c1.e2" id="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7.c1.p1" relation="true"/>
    <pair e1="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7.c1.e2" e2="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7.c1.e3" id="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7.c1.p2" relation="true"/>
    <pair e1="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7.c1.e2" e2="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7.c1.e4" id="e42c06c072d59a6eb0f4ae89f74cc4f4689644b7.c1.p3" relation="true"/>
  </chunk>
</document>
